Variable | Estimate ± SE | % PON1 AREase variation | P |
---|---|---|---|
(Intercept) | −71.40 ± 35.70 | - | 0.046 |
PON1 C-108T | −27.99 ± 2.13 | 13.61% | <2 × 10-16 |
PON1 G-162A | −2.42 ± 2.40 | 0.11% | 0.31 |
PON1 Q192R | −12.73 ± 2.24 | 1.92% | 1.73 × 10-8 |
PON1 M55L | −5.50 ± 2.31 | 0.54% | 0.017 |
Age | −0.808 ± 0.135 | 3.57% | 2.89 × 10-9 |
Sex | 16.88 ± 2.77 | 5.45% | 1.49 × 10-9 |
Current smoker | −15.34 ± 3.88 | 0.70% | 8.24 × 10-5 |
Hispanic ancestry | 6.06 ± 8.27 | 0.001% | 0.46 |
African ancestry | −12.99 ± 5.02 | 0.58% | 0.0097 |
Asian ancestry | −5.44 ± 5.29 | 0.015% | 0.30? |
Insulin use | −13.07 ± 5.76 | 1.02% | 0.023 |
ln(Dietary cholesterol)a,b,c | 53.41 ± 6.22 | 4.98% | <2 × 10-16 |
Alcohol category | 6.27 ± 1.17 | 1.84% | 1.11 × 10-7 |
ln(Vitamin C) | 4.73 ± 1.51 | 0.23% | 0.0018 |
Iron | −0.219 ± 0.0794 | 0.54% | 0.0057 |
Folate | −0.00904 ± 0.00466 | 0.19% | 0.053 |
ln(Myristic acid (14:0) intake)a | 8.95 ± 4.05 | 0.41% | 0.027 |
ln(Gadoleic acid (20:1) intake)b | 46.78 ± 12.60 | 0.27% | 0.00021 |
ln(Arachidonic acid (20:4) intake)c | −34.17 ± 21.56 | 0.15% | 0.11 |
ln(Eicosapentaenoic acid (20:5) intake) | −36.96 ± 14.24 | 0.36% | 0.0096 |